Close Get Latest Internet Explorer Get Latest Firefox Get Latest Chrome
Print Font Size: A A A

Find a Service or Condition

A B C D E F G H I
J K L M N O P Q R
S T U V W X Y Z All
Cancer Services

Pediatric Protocols

Research projects by attending physicians affiliated with
Inova Fairfax Hospital Cancer Center


Last updated July 2011

This list of open research trials is meant to be a general information resource only. 
It should not replace information given by the patient's physician.
These studies may close without warning.

In addition to the consent forms for these studies, additional general disease
information can be found on www.cancer.gov.

Learn more about clinical trials for patients at Inova Health System

Other online resources with helpful information on clinical trials:

Contact us

For information on any pediatric study, contact:ped
Keary Jane’t, Study Coordinator
703-576-7279 

Marshal Schorin, MD
Inova Fairfax Hospital for Children
3300 Gallows Road
Falls Church, VA 22042


Disease: Pediatric Bone Tumors

Study # Study Title Status
AOST0331 EURAMOS 1: Randomized Trial of the European and American Osteosarcoma Study Group to Optimize Treatment Strategies and Resectable Osteosarcoma Based On Histological Response to Pre-Operative Chemotherapy **NCI DRUG Pegylated Interferon alfa 2b Open
AEWS0331 European Ewing Tumor Working Initiative of National Groups, Ewing Tumor Studies 1999 – Metastatic Pulmonary ONLY Open
 AOST06B1  A Children's Oncology Group Protocol for Collecting and Banking Osteosarcoma Based on Histological Response to Pre-Operative Chemotherapy  Open


Disease: Pediatric Brain Tumors

Study # Study Title Status
ACNS02B3 A COG Protocol for Collecting and Banking Pediatric Brain Tumors – ALL Tumors Open
ACNS0331 A Study Evaluation Limited Target Volume Boost Irradiation and Reduced Dose Crainospinal Radiotherapy and Chemotherapy with Newly Diagnosed Standard Risk Medulloblastoma Open
 ACNS0332 Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients  Open
 ACNS0334 A Phase III, Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High-Risk Medulloblastoma in Children <36 Months Old with Intensive Induction Chemotherapy with Methotrexate Followed by Consolidation with Stem Cell Rescue versus the Same Therapy without Methofrexate  Open


Disease: Pediatric Hodgkin Disease

Study # Study Title Status
AHOD0831 A Non-Randomized, Phase III Study of Response Adapted Therapy for the Treatment of Children with Newly Diagnosed High Risk Hodgkin's Lymphoma Open


Disease: Pediatric Leukemia

Study # Study Title Status
AALL03N1 Understanding the Role of Adherence in the Ethnic Differences in Survival After Childhood Acute Lymphoblastic Leukemia Open
AALL03B1 Classification of Acute Lympoblastic Leukemia Open
AALL08B1 Classification of Acute Lymphoblastic Leukemia Open
AALL0932 Treatment for Patients with Newly Diagnosed Standard Risk B=Precursor Acute Lymphoblastic Leukemia Open
AA1106N1 Neurocognitive Function in Children with Acute Lymphoblastic Leukemia Open
AALL0434 Intensified Methotrexate, Nelarabine (Compound 506U78; IND #52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia Open
AALL0631 A Phase III Study of Risk Directed Therapy for Infants with Acute Lymphoblastic Leukemia: Randomization of Highest Risk Infants Intensive Chemotherapy +/- FLT3 Inhibition (CEP-701, Lestaurtinib; IND#76431; NSC#617807) Open
AAML0431 The Treatment of Down Syndrome Children with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Under the Age of 4 Years Open


Disease: Pediatric Nasopharyngeal

Study # Study Title Status
ARAR0331 Treatment of Childhood Nasopharyngeal Carcinoma Open


Disease: Pediatric Neuroblastoma

Study # Study Title Status
ANBL00B1 Neuroblastoma Biology Protocol Open
ANBL0532 Phase III Randomized Trial Single vs. Tandem Myeloablative Consolidation Therapy for High Risk Neuroblastoma Open
ANBL0032 Phase III Chimeric Anti-Body in High Risk NBL Open


Disease: Pediatric Rare Tumors

Study # Study Title Status
ABTR01B1 A COG Protocol for Collecting and Banking Pediatric Rare Tumors Open


Disease: Pediatric Renal Tumors

Study # Study Title Status
ARST0321 Treatment for High Risk Renal Tumors Open


Disease: Pediatric Soft Tissue Sarcoma

Study # Study Title Status
D9902 A COG Protocol for Collecting and Banking Soft Tissue Sarcoma Specimens **To enroll in front-line therapeutic study, all subjects must first be registered on this study Open
ARST0321 Phase II Study of Sulindac and Tamoxifen in Patients with Desmoid Tumors that are Recurrent or Not Amendable to Standard Therapy Open
ARST0331 Vincristine, Dactinomycin, and Lower Doses of Cyclophosphamide with or without Radiation Therapy for Patients with Newly Diagnosed Low Risk Embryonal/Botryoid/Spindle Cell Rhabdomyosarcoma Open
ARST0531 A Randomized Study of Vincristine, Dactinomycin and Cyclophosphamide (VAC) vs. (VAC) Alternating with Vincristine and Irinotecan for Patients with Intermediate Risk Rhabdomyosarcoma Open
ARST0332  Risk-Based Treatment for Non Rhabdo Soft Tissue Sarcomas Open


Disease: Pediatric Wilms

AREN0321 Treatment of High Risk Tumors Status
AREN03B2 Renal Tumors Classification, Biology and Banking Study Open
AREN0533 Treatment of Newly Dx’d Higher Risk Favorable Histology Wilms Tumor Open
AREN0532 Treatment for Very Low, Low and Standard Risk Favorable Histology Wilms Tumor Open


Disease: Late Effects and Registry

Study # Study Title Status
ATLE03N1 Late Effects Open
AALL06N1 Neuro-Cognitive Function in Children Treated for ALL Open
ACCLO5C1 A Group-Wide Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy Open
ACCRNO7 Protocol for Enrollment on the Official COG Registry, The Childhood Cancer Research Network (CCRN) Open